Skip Ribbon Commands
Skip to main content
Dr Richard Yiu

Dr Richard Yiu

MBBS (University of Melbourne, Australia), MRCP (Royal College of Physicians, UK), MMed (Internal Medicine, NUS)

Senior Consultant

Sengkang General Hospital

Specialty: Haematology

Conditions Treated by this Doctor:
Autoimmune Haematological Disorders, Lymphoproliferative Disorders, Myelodysplastic Syndrome, Myeloproliferative Neoplasms, Venous Thromboembolism.

Clinical Appointments

  • Senior Consultant SingHealth Duke-NUS Blood Cancer Centre
  • Senior Consultant Haematology Service Sengkang General HospitalSengkang General Hospital
  • Senior Consultant Department of General Medicine Sengkang General HospitalSengkang General Hospital

Profile

Dr Yiu received his graduate degree of Bachelor Medicine and Bachelor of Surgery (MBBS) from the University of Melbourne, Australia in 1998. He obtained his Membership of Royal College of Physicians in the United Kingdom and Master of Medicine (Internal Medicine) in 2004. He then received specialist training in the Department of Haematology, Singapore General Hospital from 2005 to 2008. He became a specialist haematologist since 2008.

Dr Yiu is currently a Senior Consultant in the Department of General Medicine at Sengkang General Hospital and a Senior Consultant in the Department of Haematology at Singapore General Hospital.

Education

  • MBBS (Australia)
  • MRCP(UK)
  • MMed Internal Medicine, National University of Singapore

Professional Appointments and Committee Memberships

  • Senior Clinical Lecturer, NUS Yong Loo Lin School of Medicine
  • Executive member, SingHealth Duke NUS-Blood Cancer Centre 
  • Member, Singapore Society of Haematology

Awards

  • ​SingHealth Health Quality Service Award - Star Award, 2015
  • Singapore General Hospital Service Quality Award, 2013
  • SingHealth Health Quality Service Award - Silver Award, 2013
  • Singapore General Hospital Service Quality Award, 2009

Research Interests

Publications

  • Treatment of elderly patients with acute myeloid leukemia with azacitidine results in fewer hospitalization days and infective complications but similar survival compared with intensive chemotherapy.  Lao Z, Yiu R, Wong GC, Ho A. Asia Pac J Clin Oncol 2015;11:54-61.
  • Impact of pegylated filgrastim in comparison to filgrastim for patients with acute myeloid leukaemia (AML) on high-dose cytarabine (HIDAC) consolidation chemotherapy.  Kam G, Yiu R, Loh Y, Ang AL, Yueh LL, Goh YT, Wong GC. Support Care Cancer 2015;23:643-9.
  • Hemophagocytosis and complex marrow karyotype in metastatic adenocarcinoma.  Richard Cheung Yiu and Lai-Ching Lau. Blood 2013;122:3402.
  • Cold agglutinin disease with prolymphocytic leukemia.  Richard Cheung Yiu and Sim-Leng Tien. Blood 2012;119:5069.
  • Positron emission tomography findings in patients with lymphoma-associated haemophagocytic syndrome.  Richard Cheung Yiu, Yung Hsiang Kao, Colin Philips, Daryl Tan. Singapore Medical Journal 2011;52:e156-e159.
  • A patient with extramedullary acute myeloid leukaemia involving brachial plexus: case reports and review of literatures.  Cheung Richard Yiu, Lai Heng Lee, Kumar M Prakash, Gee Chuan Wong.

Research Trials